- Coordinator
- Genopole Gip, France
- Runs
- 1 March 2023 to 30 June 2025
- Status
- Finished
- EU funding
- €500k
- Total cost
- —
- Partners
- 6 organisations in 4 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101095912
What the project is doing
In the project's own words, from its summary on CORDIS.
COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…).
COBIOE will reach the following objectives:- Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities- Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain.- Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players.- Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakersCOBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing.
Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Genopole Gip | Evry | France | Coordinator |
| Council of European Bioregions | Bruxelles / Brussel | Belgium | Participant |
| Scanbalt Mtu | Tartu | Estonia | Participant |
| Eit Health Clc France | Paris | France | Participant |
| Eit Health Hub France | Paris | France | Participant |
| Health Cluster Portugal - Associacao do Polo de Competitividade da Saude | Leca Do Balio | Portugal | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI